Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Alnylam Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

11 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ALNYLAM PHARMACEUTICALS, INC. (ALNY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

17 Apr 2014 Thomson Reuters Stock Report 11 $25.00

ALNYLAM PHARMACEUTICALS INC (ALNY) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

17 Apr 2014 Pechala's Reports 1 $25.00

ValuEngine Detailed Valuation Report for ALNY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

17 Apr 2014 ValuEngine, Inc. 11 $25.00

"The Economy Matters" Report for ALNY: the economy's impact on ALNY's price and risk, featuring the powerful Economic Climate Rating

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating. Based on a sophisticated econometric framewor...

15 Apr 2014 MacroRisk Analytics/EconomicInvestor 7 $25.00

ALNY - Alnylam Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report

www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

12 Apr 2014 Alpha Street Research 9 $24.00

Alnylam Pharmaceuticals

12 Apr 2014 S&P Capital IQ – STARS Reports 11 $127.00

ALNYLAM PHARMACEUTICALS INC (ALNY) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

12 Apr 2014 Pechala's Reports 1 $15.00

Value Graph: ALNYLAM PHARM -- ALNY

11 Apr 2014 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALNYLAM PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

11 Apr 2014 Jefferson Research 11 $20.00